Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03879187
Other study ID # R13-P171
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date March 2, 2015
Est. completion date May 22, 2018

Study information

Verified date March 2019
Source Loughborough University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This study determined the effect of 7 days of high-fat overfeeding on whole-body glycaemic control, glucose kinetics, skeletal muscle insulin signalling, and markers of skeletal muscle microvascular function in 15 healthy young individuals.


Description:

Fifteen healthy, young individuals underwent metabolic testing before and after 7 days of high-fat overfeeding. We determined whole-body glycaemic control, glucose kinetics, skeletal muscle insulin signalling, and markers of skeletal muscle microvascular function. Stable isotope tracers were used to assess the rate of appearance of glucose from the gut, liver glucose output and whole-body glucose disposal. Insulin signalling was determined by Western blotting of skeletal muscle tissue. Microvascular function was assessed through the use of quantitative immunofluorescence microscopy. These measurements were performed both postabsorptively and following the ingestion of 50 grams of glucose + 15 grams of protein.


Recruitment information / eligibility

Status Completed
Enrollment 15
Est. completion date May 22, 2018
Est. primary completion date May 22, 2018
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 40 Years
Eligibility Inclusion Criteria:

- Aged between 18 and 40 years

- Physically active

- Non-smoker

- Not taking any medication known to interfere with the study

- No history of cardiovascular disease or diabetes

- Weight stable for the last 6 months

Exclusion Criteria:

- Outside of age range

- Sedentary

- Smoker

- Taking medication known to interfere with the study

- History of cardiovascular disease or diabetes

- Unstable weight within last 6 months

Study Design


Related Conditions & MeSH terms


Intervention

Dietary Supplement:
High-fat, high-energy diet
Participants consumed a diet that was high in fat and high in energy

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Loughborough University

Outcome

Type Measure Description Time frame Safety issue
Primary Change in glucose concentration Venous blood samples were obtained the day before and the day after the 7 day high-fat diet. Glucose was reported as mmol/L. Immediately before and after the 7 day high-fat diet (i.e., measurements were made 7 days apart)
Primary Change in insulin concentration Venous blood samples were obtained the day before and the day after the 7 day high-fat diet. Insulin was reported as pmol/L. Immediately before and after the 7 day high-fat diet (i.e., measurements were made 7 days apart)
Primary Change in glucose kinetics (i.e., rate of appearance and disappearance) assessed using isotope tracers Glucose kinetics were assessed the day before and the day after the 7 day high-fat diet. Data expressed as umol/kg/min. Immediately before and after the 7 day high-fat diet (i.e., measurements were made 7 days apart)
Primary Change in skeletal muscle insulin signalling AKT and AS160 phosphorylation was determined by Western blotting of skeletal muscle. Data are expressed as arbitrary units. Immediately before and after the 7 day high-fat diet (i.e., measurements were made 7 days apart)
Primary Change in markers of microvascular function endothelial nitric oxide synthase was determined in terminal arterioles by quantitative immunofluorescence microscopy that was performed on sections of skeletal muscle tissue. Data presented as arbitrary units. Immediately before and after the 7 day high-fat diet (i.e., measurements were made 7 days apart)
Secondary Change intramuscular triglyceride content Intramuscular triglyceride content was determined by quantitative immunofluorescence microscopy that was performed on sections of skeletal muscle tissue. Data presented as arbitrary units. Immediately before and after the 7 day high-fat diet (i.e., measurements were made 7 days apart)
See also
  Status Clinical Trial Phase
Recruiting NCT06052553 - A Study of TopSpin360 Training Device N/A
Completed NCT05511077 - Biomarkers of Oat Product Intake: The BiOAT Marker Study N/A
Recruiting NCT04632485 - Early Detection of Vascular Dysfunction Using Biomarkers From Lagrangian Carotid Strain Imaging
Completed NCT05931237 - Cranberry Flavan-3-ols Consumption and Gut Microbiota in Healthy Adults N/A
Terminated NCT04556032 - Effects of Ergothioneine on Cognition, Mood, and Sleep in Healthy Adult Men and Women N/A
Completed NCT04527718 - Study of the Safety, Tolerability and Pharmacokinetics of 611 in Adult Healthy Volunteers Phase 1
Completed NCT04107441 - AX-8 Drug Safety, Tolerability and Plasma Levels in Healthy Subjects Phase 1
Completed NCT04998695 - Health Effects of Consuming Olive Pomace Oil N/A
Completed NCT04065295 - A Study to Test How Well Healthy Men Tolerate Different Doses of BI 1356225 Phase 1
Completed NCT01442831 - Evaluate the Absorption, Metabolism, And Excretion Of Orally Administered [14C] TR 701 In Healthy Adult Male Subjects Phase 1
Terminated NCT05934942 - A Study in Healthy Women to Test Whether BI 1358894 Influences the Amount of a Contraceptive in the Blood Phase 1
Recruiting NCT05525845 - Studying the Hedonic and Homeostatic Regulation of Food Intake Using Functional MRI N/A
Completed NCT05515328 - A Study in Healthy Men to Test How BI 685509 is Processed in the Body Phase 1
Completed NCT04967157 - Cognitive Effects of Citicoline on Attention in Healthy Men and Women N/A
Completed NCT05030857 - Drug-drug Interaction and Food-effect Study With GLPG4716 and Midazolam in Healthy Subjects Phase 1
Recruiting NCT04714294 - Evaluate the Safety, Tolerability and Pharmacokinetics Characteristics of HPP737 in Healthy Volunteers Phase 1
Recruiting NCT04494269 - A Study to Evaluate Pharmacokinetics and Safety of Tegoprazan in Subjects With Hepatic Impairment and Healthy Controls Phase 1
Completed NCT04539756 - Writing Activities and Emotions N/A
Recruiting NCT04098510 - Concentration of MitoQ in Human Skeletal Muscle N/A
Completed NCT03308110 - Bioavailability and Food Effect Study of Two Formulations of PF-06650833 Phase 1